Signs of movement in access and stewardship planning in R&D, from a low base
Pharma companies are missing opportunities to make antibiotics available
Progress in how pharma companies tackle overselling antimicrobials
Pfizer is the first company to share raw data on the spread of resistance
Pipeline: Which companies are developing new treatments for the most threatening bacteria and fungi?
Portfolios: Which companies produce important antibacterial and antifungal products?